64th Annual Meeting of the Biophysical Society

//64th Annual Meeting of the Biophysical Society
Loading Events
This event has passed.

Metrion Biosciences will be attending and exhibiting at the 64th Annual Meeting of the Biophysical Society to be held at the San Diego Convention Centre in San Diego, California from 15th – 19th February 2020.

Metrion will be exhibiting at booth number 214 in the Exhibits Hall for the duration of the meeting and will also be attending the ‘Drug Discovery in Ion Channels XX’ Satellite meeting to take place on Friday 14th February.

Metrion’s CSO Dr Marc Rogers will be presenting a talk entitled: “Screening Toxins as Ion Channel Therapeutics on Automated Patch Clamp Systems: Kv1.3 Case Study” at 15.30-16.00 at the Satellite Meeting on 14th February.

Marc will also be presenting at the event “Beyond Ion Channels and Transporters: Snapshots of the State-of the-Art Solution” organised by Nanion Technologies on Monday 17th February 12:30 – 14:00  in Room 33C at the San Diego Convention Centre.

Please also visit our cardiac safety poster at B434

Please email info@metrionbiosciences.com if you would like to arrange a meeting with our booth representatives, Dr Marc Rogers and Dr Robert Kirby.

Metrion Biosciences is a UK-based Contract Research Organization (CRO) located within the Cambridge bio cluster, one of Europe’s largest bioscience research hubs. Our state of the art laboratories at Granta Park house high quality facilities for native and engineered cell line and induced pluripotent stem cell culture, a comprehensive suite of automated patch clamp platforms, multiple manual patch clamp rigs, fluorescence-based screening capability and laboratory data management and reporting systems. Our company is focused upon delivering a range of high quality ion channel drug discovery services. We provide highly skilled electrophysiology screening services to support client medicinal chemistry optimisation programmes, CiPA compliant cardiac safety profiling assays, neuroscience assays and translational assays. We combine in depth target class knowledge and high quality screening assays with highly experienced and collaborative drug discovery managers to keep your research focused upon meeting both objectives and timelines. Our team has successfully delivered many projects on behalf of our clients from once off screening projects to fully integrated drug discovery programmes delivering clinical candidates.